NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 45 filers reported holding NEUBASE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $9,000 | -72.7% | 22,309 | +28.4% | 0.00% | – |
| Q1 2022 | $33,000 | -57.1% | 17,375 | -36.2% | 0.00% | – |
| Q4 2021 | $77,000 | -24.5% | 27,252 | -3.4% | 0.00% | – |
| Q3 2021 | $102,000 | -87.8% | 28,200 | -83.8% | 0.00% | -100.0% |
| Q2 2021 | $834,000 | +143.9% | 174,020 | +276.2% | 0.00% | – |
| Q1 2021 | $342,000 | +147.8% | 46,253 | +134.8% | 0.00% | – |
| Q4 2020 | $138,000 | -96.3% | 19,697 | -95.3% | 0.00% | -100.0% |
| Q2 2020 | $3,682,000 | +2104.8% | 419,325 | +1689.3% | 0.01% | – |
| Q1 2020 | $167,000 | -18.9% | 23,435 | -18.2% | 0.00% | – |
| Q4 2019 | $206,000 | – | 28,653 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 470,524 | $494,000 | 0.50% |
| CARNEGIE MELLON UNIVERSITY | 939,412 | $986,000 | 0.50% |
| CM Management, LLC | 370,000 | $389,000 | 0.41% |
| Decheng Capital Management III (Cayman), LLC | 1,000,000 | $1,050,000 | 0.40% |
| Sio Capital Management, LLC | 906,445 | $952,000 | 0.36% |
| AIGH Capital Management LLC | 1,027,585 | $1,079,000 | 0.28% |
| Greenlight Capital | 2,727,027 | $2,863,000 | 0.22% |
| Worth Venture Partners, LLC | 256,553 | $249,000 | 0.15% |
| PERKINS CAPITAL MANAGEMENT INC | 81,500 | $86,000 | 0.09% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $327,000 | 0.01% |